{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:44:49Z","timestamp":1771328689440,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2113-M-001 -019 -MY2"],"award-info":[{"award-number":["113-2113-M-001 -019 -MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2113-M-110-009"],"award-info":[{"award-number":["113-2113-M-110-009"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2113-M-001 -032 -MY3"],"award-info":[{"award-number":["111-2113-M-001 -032 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108994","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:23:53Z","timestamp":1758540233000},"page":"108994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design and synthesis of polyhydroxylated azabicyclo[3.3.1]nonane as selective lysosomal \u03b1-glucosidase stabilizers enhancing cellular uptake"],"prefix":"10.1016","volume":"165","author":[{"given":"Huang-Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ser John Lynon P.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Lan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Hsuan","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Ning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chieh","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108994_bb0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1039\/B915870G","article-title":"Glycosidase inhibition: assessing mimicry of the transition state","volume":"8","author":"Gloster","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0010","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1039\/D1OB00382H","article-title":"Iminosugars as glycosyltransferase inhibitors","volume":"19","author":"Conforti","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drudis.2010.08.017","article-title":"Iminosugars past, present and future: medicines for tomorrow","volume":"16","author":"Horne","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108994_bb0020","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1021\/jm301304e","article-title":"\u0391-1-C-Butyl-1,4-dideoxy-1,4-imino-l-arabinitol as a second-generation Iminosugar-based Oral \u03b1-glucosidase inhibitor for improving postprandial hyperglycemia","volume":"55","author":"Kato","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/hlca.202300222","article-title":"New selective inhibitors of \u03b1-glucosidase for the treatment of type\u00a02 diabetes mellitus","volume":"107","author":"Khanchouch","year":"2024","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2025.108994_bb0030","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1039\/c2ob25727k","article-title":"Iminosugar\u2013ferrocene conjugates as potential anticancer agents","volume":"10","author":"Hottin","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0035","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1039\/D1SC05894K","article-title":"Harnessing natural-product-inspired combinatorial chemistry and computation-guided synthesis to develop N-glycan modulators as anticancer agents","volume":"13","author":"Chen","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.108994_bb0040","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/acs.jmedchem.2c01750","article-title":"Structure-based design of potent iminosugar inhibitors of endoplasmic reticulum \u03b1-glucosidase I with anti-SARS-CoV-2 activity","volume":"66","author":"Karade","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/BST20160182","article-title":"Iminosugar antivirals: the therapeutic sweet spot","volume":"45","author":"Alonzi","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bioorg.2025.108994_bb0050","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1002\/chem.202101408","article-title":"Iminosugar C-glycosides work as pharmacological chaperones of NAGLU, a glycosidase involved in MPS IIIB rare disease","volume":"27","author":"Zhu","year":"2021","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2025.108994_bb0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-009-1077-0","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin increases \u03b1-galactosidase a levels in Fabry patient cell lines","volume":"32","author":"Benjamin","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bioorg.2025.108994_bb0060","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"Porto","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioorg.2025.108994_bb0065","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1038\/ncomms7903","article-title":"Direct synthesis of imino-C-nucleoside analogues and other biologically active iminosugars","volume":"6","author":"Bergeron-Brlek","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108994_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202217809","article-title":"Influence of side chain conformation on the activity of glycosidase inhibitors","volume":"62","author":"Tseng","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108994_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202207974","article-title":"Pharmacological chaperones for GCase that switch conformation with pH enhance enzyme levels in Gaucher animal models","volume":"61","author":"Santana","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108994_bb0080","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1039\/C9SC06334J","article-title":"Synthesis, conformational analysis and in vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment","volume":"11","author":"Bermejo","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.108994_bb0085","series-title":"Tactics and Strategies for the Synthesis of Iminosugar C-Glycosides: A Review, Tetrahedron: Asymmetry","first-page":"672","volume":"20","author":"Compain","year":"2009"},{"key":"10.1016\/j.bioorg.2025.108994_bb0090","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/bj1910649","article-title":"Inhibition of lysosomal \u03b1-mannosidase by swainsonine, an indolizidine alkaloid isolated from Swainsona canescens","volume":"191","author":"Dorling","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2025.108994_bb0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0003-9861(83)90247-3","article-title":"Swainsonine, a potent mannosidase inhibitor, elevates rat liver and brain lysosomal \u03b1-d-mannosidase, decreases Golgi \u03b1-d-mannosidase II, and increases the plasma levels of several acid hydrolases","volume":"224","author":"Tulsiani","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.108994_bb0100","doi-asserted-by":"crossref","first-page":"11734","DOI":"10.1039\/D4CC04514A","article-title":"Structure-guided design of C3-branched swainsonine as potent and selective human Golgi \u03b1-mannosidase (GMII) inhibitor","volume":"60","author":"Koemans","year":"2024","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.108994_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.82.1.93","article-title":"Castanospermine inhibits alpha-glucosidase activities and alters glycogen distribution in animals","volume":"82","author":"Saul","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.108994_bb0110","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1039\/c0cc00446d","article-title":"Synthesis of N-, S-, and C-glycoside castanospermine analogues with selective neutral \u03b1-glucosidase inhibitory activity as antitumour agents","volume":"46","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.108994_bb0115","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1021\/acs.joc.7b01494","article-title":"Polyhydroxylated Quinolizidine Iminosugars as Nanomolar selective inhibitors of \u03b1-glucosidases","volume":"82","author":"Vieira Da Cruz","year":"2017","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0120","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/acs.joc.5b00342","article-title":"Design and synthesis of Labystegines, hybrid Iminosugars from LAB and Calystegine, as inhibitors of intestinal \u03b1-glucosidases: binding conformation and interaction for ntSI","volume":"80","author":"Kato","year":"2015","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0125","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/jacs.8b02399","article-title":"Gluco-1H-imidazole: a new class of azole-type \u03b2-glucosidase inhibitor","volume":"140","author":"Schr\u00f6der","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108994_bb0130","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/ja066961g","article-title":"Glycosidase inhibition: an assessment of the binding of 18 putative transition-state mimics","volume":"129","author":"Gloster","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108994_bb0135","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/hlca.19970800509","article-title":"Synthesis via a carbohydrate-derived M\u00fcnchnone of Pyrrolopyridines (Indolizines) and imidazopyridines, and their evaluation as inhibitors of \u03b2-D-glucosidases","volume":"80","author":"Granier","year":"1997","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.bioorg.2025.108994_bb0140","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1039\/b906968b","article-title":"Glycosidase inhibition by ring-modified castanospermine analogues: tackling enzyme selectivity by inhibitor tailoring","volume":"7","author":"Aguilar-Moncayo","year":"2009","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/dta.1798","article-title":"Looking for protein stabilizing drugs with thermal shift assay","volume":"7","author":"Andreotti","year":"2015","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.bioorg.2025.108994_bb0150","doi-asserted-by":"crossref","first-page":"2200222","DOI":"10.1002\/pmic.202200222","article-title":"The use of pharmacological chaperones in rare diseases caused by reduced protein stability","volume":"22","author":"Gil-Mart\u00ednez","year":"2022","journal-title":"Proteomics"},{"key":"10.1016\/j.bioorg.2025.108994_bb0155","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/mt.2015.62","article-title":"Pharmacological chaperone therapy: preclinical development, clinical translation, and prospects for the treatment of lysosomal storage disorders","volume":"23","author":"Parenti","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioorg.2025.108994_bb0160","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1111\/j.1742-4658.2007.06041.x","article-title":"Active-site-specific chaperone therapy for Fabry disease","volume":"274","author":"Fan","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2025.108994_bb0165","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/mt.2014.138","article-title":"A chaperone enhances blood \u03b1-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy","volume":"22","author":"Parenti","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bioorg.2025.108994_bb0170","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1021\/jo202054g","article-title":"Synthesis and evaluation of eight- and four-membered Iminosugar analogues as inhibitors of testicular ceramide-specific glucosyltransferase, testicular \u03b2-glucosidase 2, and other Glycosidases","volume":"77","author":"Lee","year":"2012","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0175","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","article-title":"\u0392-Glucosidase 2 (GBA2) activity and Imino sugar pharmacology","volume":"288","author":"Ridley","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0180","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0006-2952(99)00384-6","article-title":"N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo","volume":"59","author":"Andersson","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108994_bb0185","first-page":"119","article-title":"Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated Iminosugars, ACS med","volume":"2","author":"Ghisaidoobe","year":"2011","journal-title":"Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108994_bb0190","doi-asserted-by":"crossref","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","article-title":"Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses","volume":"15","author":"Butters","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.bioorg.2025.108994_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2016.10.004","article-title":"Rapid preparation of (3R,4S,5R) polyhydroxylated pyrrolidine-based libraries to discover a pharmacological chaperone for treatment of Fabry disease","volume":"126","author":"Cheng","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202200172","article-title":"Synthesis of Nitrone-derived Pyrrolidine scaffolds and their combinatorial libraries to develop selective \u03b1-l-Rhamnosidase inhibitors","volume":"17","author":"Chen","year":"2022","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.bioorg.2025.108994_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117129","article-title":"Harnessing polyhydroxylated pyrrolidines as a stabilizer of acid alpha-glucosidase (GAA) to enhance the efficacy of enzyme replacement therapy in Pompe disease","volume":"78","author":"Li","year":"2023","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115005","article-title":"Discovery of small-molecule protein stabilizers toward exogenous alpha-l-iduronidase to reduce the accumulated heparan sulfate in mucopolysaccharidosis type I cells","volume":"247","author":"Lin","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0215","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1021\/jacsau.3c00684","article-title":"Mechanistic insights into dibasic Iminosugars as pH-selective pharmacological chaperones to stabilize human \u03b1-galactosidase","volume":"4","author":"Li","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.bioorg.2025.108994_bb0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s42004-024-01164-9","article-title":"A practical synthesis of nitrone-derived C5a-functionalized isofagomines as protein stabilizers to treat Gaucher disease","volume":"7","author":"Li","year":"2024","journal-title":"Commun. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0225","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1021\/acs.orglett.5b01505","article-title":"Hydroxymethyl-branched polyhydroxylated indolizidines: novel selective \u03b1-glucosidase inhibitors","volume":"17","author":"Boisson","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108994_bb0230","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1021\/acs.orglett.5b02029","article-title":"Oxidation of N,N-disubstituted hydroxylamines to nitrones with hypervalent iodine reagents","volume":"17","author":"Matassini","year":"2015","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108994_bb0235","doi-asserted-by":"crossref","first-page":"12247","DOI":"10.1016\/j.tet.2007.09.065","article-title":"Intramolecular 1,3-dipolar cycloaddition reactions in targeted syntheses","volume":"63","author":"Nair","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108994_bb0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/BF00899245","article-title":"Synthese von (\u00b1)-Adalin","volume":"111","author":"G\u00f6ssinger","year":"1980","journal-title":"Monatshefte f\u00fcr Chemie \/ Chem Monthly"},{"key":"10.1016\/j.bioorg.2025.108994_bb0245","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0040-4020(00)01138-8","article-title":"Ring-selective synthesis of O-heterocycles from acyclic 3-O-allyl-monosaccharides via intramolecular nitrone\u2013alkene cycloaddition","volume":"57","author":"Shing","year":"2001","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108994_bb0250","doi-asserted-by":"crossref","first-page":"9456","DOI":"10.1002\/chem.201600655","article-title":"Debenzylative Cycloetherification: an overlooked key strategy for complex tetrahydrofuran synthesis","volume":"22","author":"Tikad","year":"2016","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2025.108994_bb0255","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ejmech.2017.12.036","article-title":"Synthesis of (3S,4S,5S)-trihydroxylpiperidine derivatives as enzyme stabilizers to improve therapeutic enzyme activity in Fabry patient cell lines","volume":"144","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0260","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1021\/acs.jmedchem.1c01673","article-title":"5-C-branched Deoxynojirimycin: strategy for designing a 1-Deoxynojirimycin-based pharmacological chaperone with a Nanomolar affinity for Pompe disease","volume":"65","author":"Kato","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0265","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41467-017-01263-3","article-title":"Structure of human lysosomal acid \u03b1-glucosidase\u2013a guide for the treatment of Pompe disease","volume":"8","author":"Roig-Zamboni","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108994_bb0270","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.chembiol.2011.10.012","article-title":"The molecular basis of pharmacological chaperoning in human \u03b1-galactosidase","volume":"18","author":"Guce","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108994_bb0275","doi-asserted-by":"crossref","first-page":"17400","DOI":"10.1073\/pnas.1203924109","article-title":"Pharmacological chaperones for human \u03b1-N-acetylgalactosaminidase","volume":"109","author":"Clark","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.108994_bb0280","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.1002\/anie.202002850","article-title":"Imino- and Azasugar protonation inside human acid \u03b2-glucosidase, the enzyme that is defective in Gaucher disease","volume":"59","author":"Matassini","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108994_bb0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/anie.200905597","article-title":"Structural basis of \u03b1-Fucosidase inhibition by Iminocyclitols with Ki values in the Micro- to Picomolar range","volume":"49","author":"Wu","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108994_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107555","article-title":"Ortiz Mellet, sp2-Iminosugar azobenzene O-glycosides: light-sensitive glycosidase inhibitors with unprecedented tunability and switching factors","volume":"150","author":"Rivero-Barbarroja","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108994_bb0295","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbrc.2008.02.125","article-title":"Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase","volume":"369","author":"Shen","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108994_bb0300","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/mt.2011.271","article-title":"Co-administration with the pharmacological chaperone AT1001 increases recombinant human \u03b1-galactosidase a tissue uptake and improves substrate reduction in Fabry mice","volume":"20","author":"Benjamin","year":"2012","journal-title":"Mol. Ther."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:29:26Z","timestamp":1762223366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":60,"alternative-id":["S0045206825008740"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108994","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of polyhydroxylated azabicyclo[3.3.1]nonane as selective lysosomal \u03b1-glucosidase stabilizers enhancing cellular uptake","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108994"}}